Jasper Therapeutics Inc
NASDAQ:JSPR
Jasper Therapeutics Inc
NASDAQ:JSPR
Price:
23.95 USD
-2.32%
Market Closed
Updated:
Jun 11, 2024
Jasper Therapeutics Inc
Other Current Liabilities
|
Jasper Therapeutics Inc
Other Current Liabilities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Jasper Therapeutics Inc
NASDAQ:JSPR
|
Other Current Liabilities
$317k
|
CAGR 3-Years
74%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Other Current Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Current Liabilities
$3.3B
|
CAGR 3-Years
149%
|
CAGR 5-Years
406%
|
CAGR 10-Years
26%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Current Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Current Liabilities
$648.6m
|
CAGR 3-Years
32%
|
CAGR 5-Years
8%
|
CAGR 10-Years
27%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Current Liabilities
$516.7m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
23%
|
See Also
What is Jasper Therapeutics Inc's Other Current Liabilities?
Other Current Liabilities
317k
USD
317k
USD
Based on the financial report for Dec 31, 2023, Jasper Therapeutics Inc's Other Current Liabilities amounts to 317k USD.
What is Jasper Therapeutics Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 3Y
74%
74%
Over the last year, the Other Current Liabilities growth was 67%. The average annual Other Current Liabilities growth rates for Jasper Therapeutics Inc have been 74% over the past three years .
You don't have any saved screeners yet
